by Truveta Staff | Mar 22, 2023 | News
Today, Truveta and Alpine Immune Sciences, Inc. announced a strategic partnership to help accelerate clinical trial recruitment for povetacicept, Alpine’s dual B cell cytokine antagonist being developed for multiple B cell-mediated autoimmune and inflammatory...
by Truveta Staff | Oct 12, 2021 | Culture
For Denesh Pohar, Truveta’s vision of Saving Lives with Data is easy to get excited about — and a big responsibility. We sat down with Denesh to learn more about his experience and his motivation as a director of engineering at Truveta, to make data more...
